PEOPLE - Bio-Rad Laboratories makes senior appointments:
This article was originally published in Clinica
Bio-Rad Laboratories (US) has recently made two new senior appointments. George Bers is named corporate vice-president of its molecular bioscience group. Mr Bers, who has been with the company for 20 years, was formerly molecular bioscience group manager. Sanford Wadler becomes Bio-Rad's corporate vice- president, in addition to his current position of general counsel and corporate secretary.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.